Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells
1Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands;2Division of Pharmacology and Chemotherapy, Department of Internal Medicine, University of Pisa, Italy;3Eli Lilly & Co, Indianapolis, IN, USA